The Impact of Preclinical Irreproducibility on Drug Development

The Increasing Urgency for Standards in Basic Biologic Research

(2014) L. P. Freedman et al.   CANCER RESEARCH

Policy: NIH plans to enhance reproducibility

(2014) Francis S. Collins et al.   NATURE

Asia's Ascent — Global Trends in Biomedical R&D Expenditures

(2014) Justin Chakma et al.   NEW ENGLAND JOURNAL OF MEDICINE

On the reproducibility of science: unique identification of research resources in the biomedical literature

(2013) Nicole A. Vasilevsky et al.   PeerJ

Raise standards for preclinical cancer research

(2012) C. Glenn Begley et al.   NATURE

Drug development and clinical trials—the path to an approved cancer drug

(2012) Eric H. Rubin et al.   Nature Reviews Clinical Oncology

Tracking Replicability as a Method of Post-Publication Open Evaluation

(2012) Joshua K. Hartshorne et al.   Frontiers in Computational Neuroscience

Believe it or not: how much can we rely on published data on potential drug targets?

(2011) Florian Prinz et al.   NATURE REVIEWS DRUG DISCOVERY

Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges

(2009) Alvis Brazma   TheScientificWorldJOURNAL